Daye
Daye is a gynecological health company that creates products and services for vaginal treatment.
About Daye
Daye is a gynecological health company that creates products and services for vaginal treatment. Its tampon-based at-home vaginal microbiome screening kit allows women to test themselves at their leisure. The kit is intended to screen for vaginal infections such as thrush and bacterial vaginosis (BV), as well as disruptions to the microbiome, which could put women at risk of STIs, gynecological cancers, and fertility and IVF complications. Daye will also launch a comprehensive digital platform for gynae health, with the goal of reducing pain, shame, and wasted time for women as they navigate their health journey from their first period to menopause. The company was founded in 2017
Company Facts
- Headquarters
- London
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00011_00050
- Funding Stage
- early_stage_venture
- Total Funding
- $17,139,086
- Last Funding Type
- series_a
- Last Funding Date
- 2022-10-26
- Website
- yourdaye.com
Industries & Categories
Biotechnology, Cannabis, Health Care, Personal Health, Women's
Social Links
Canonical: https://fsome.com/organization/daye-53762 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.